The FDA has provided an update on the status of U.S. FDA inspections outside of the U.S. in response to the COVID-19 outbreak. The FDA is postponing most foreign inspections through April, effective immediately. Inspections outside the U.S. deemed mission-critical will still be considered on a case-by-case basis. The FDA based this decision on State Department Level four travel advisories in which travel is prohibited for U.S. government employees, CDC and Prevention travel recommendations, ...